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Abstract: Hypoglycemic effects and the use of kelp in diabetes mellitus (DM) model rats 
induced by alloxan were investigated. Sixty healthy male rats were used to establish DM 
models by injecting alloxan intraperitoneally. Kelp powder was added to the general forage 
for the rats. The levels of fasting blood glucose (FBG) were determined by an automatic 
blood glucose device. Electrochemiluminescence immunoassay was applied to determine 
the serum levels of insulin. The serum levels of malondialdehyde (MDA) were measured 
by thiobarbituric acid assay and nitric oxide (NO) by nitrate reductase assay. The activities 
of superoxide dismutase (SOD) were determined by xanthinoxidase assay and glutathione 
peroxidase (GSH-Px) by chemical colorimetry. The shape and structure of islet cells were 
observed with Hematine-Eosin staining, and the expression of superoxide dismutase (SOD) 
and  inducible  nitric  oxide  synthase  (iNOS)  in  islet  cells  were  detected  by 
immunohistochemical  assay.  The  results  showed  that  the  serum  levels  of  insulin  after 
treatment with kelp powder increased significantly compared to those in the DM-model 
group,  while  the  FBG  in  the  medium-high  dose  treated  groups  decreased  significantly 
compared to those in the DM-model group (P < 0.05). The levels of MDA and NO in the 
kelp powder groups were lower than those in the DM-model group, while the activities of 
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SOD and GSH-Px were higher than those in the DM-model group, of which a significant 
difference existed between the medium-high dose treated groups and the DM-model group 
(P < 0.05). The shape and structure of islet cells improved with the up-expressing SOD and 
down-expressing iNOS in the medium-high dose treated groups compared to those in the 
DM-model group (P < 0.05). There were no significant differences between the medium 
and high dose treated groups, all above indexes (P > 0.05). It is suggested that kelp might 
aid recovery of the the islet cell secreting function and reduce the level of FBG by an 
antioxidant effect. 
Keywords: kelp; diabetes mellitus; alloxan; oxidative stress; rats  
 
1. Introduction  
Diabetes  mellitus  (DM)  is  a  common  disease  in  the  world  and  type  2  DM  accounts  for  about  
90%–95%  of  cases.  Although  the  etiology  of  type  2  DM  is  complex  and  its  pathogenesis  is  not 
completely understood, the disease is associated with the level of free radicals and the antioxidant 
system dysfunction. It has been well established that oxidative stress is a commonly used approach to 
DM and its complications [1]. Malondialdehyde (MDA) can reflect oxygen free radicals (OFR) in the 
body that are produced when OFR oxidizes polyunsaturated fatty acids in bio-membranes [2]. The gas 
free radical, nitric oxide (NO), is important in initiating type 2 DM, insulin resistance and secondary 
effects as well as the islet beta cell function obstacle [3,4]. The natural enzyme superoxide dismutase 
(SOD) can capture free radicals in the body and the catalytic oxidation enzyme glutathione peroxidase 
(GSH-Px) is widespread in the body. These enzymes work to eliminate OFR in the body when decline 
in activity leads to OFR accumulation [5,6]. 
Laminaria japonica (L. japonica) is a widely cultivated kelp, with China being the largest producer [7]. 
In China, the kelp is used for food in daily life and also used in traditional medicine. According to the 
“Compendium of Materia Medica” [8], kelp is cold, salty, has efficacy in clearing water, is soft, firm, 
dissipating and can dissolve phlegm [9], as well as alleviate edema,and eliminate carbuncle. Kelp 
belongs  to  the  Phaeophyta  Laminariaceae  Laminaria,  containing  laminarin,  ammonium  alginate, 
mannitol, vitamins, amino acids and various normal and trace elements, with a variety of 40 active 
components [10]. The variety of physiological functions of the kelp relate to the biological activity of 
polysaccharides  which  can  improve  the  immunity  function,  anti-aging,  anti-tumor  [11],  
anti-atheroscloresis, anti-diabetics [12,13] and other such biological activity. Until now, there has been 
only  limited  research  and  reports  on  L.  japonica’s  anti-diabetic  functions  and  mechanism  [14]. 
Therefore, the experiment described in this paper expands the exploration of the hypoglycemic effect 
along with a possible mechanism of the effect of kelp on alloxan-induced diabetic rats. Int. J. Mol. Sci. 2012, 13                       
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2. Results and Discussion 
2.1. General Situation 
Before alloxan was injected, all rats reacted nimbly, had hair that was bright and smooth and there 
was no significant variation in body weights (F = 0.05, q = 0.03–0.55, P > 0.05). After alloxan was 
injected and before kelp powder, forage was administered, and the animals showed typical signs of 
diabetes mellitus: clumsiness, slow actions, dull colored fur and marasmus. Average body weights 
reduced significantly before alloxan was injected (F = 1643.22, q = 21.77–104.53, P < 0.05) and there 
was no significant difference between the weights of kelp-treated rats and DM-model rats (P > 0.05). 
After kelp powder forage was administered, the action and hair color of animals in kelp treated and 
DM-model groups recovered gradually, with body weight becoming significantly higher than before 
treatment, lower than that of the control group (F = 149.29, q = 22.82–29.00, P < 0.05). Average body 
weight of animals in the DM-model and kelp-treated groups was significant lower than that in the 
control group (F = 149.29, q = 22.82–30.06, P < 0.05). There was no significant difference between 
the  low-dose  group  and  DM-model  rats  (P  >  0.05).  Average  body  weight  of  animals  in  the  
medium-dose and high-dose groups was significantly higher than in the DM-model rats   (P < 0.05), but 
there was no significant difference between medium-dose and high-dose groups (P > 0.05) (Table 1). 
Table 1. The average body weights of animals in the experiment (x ± s, Unit: g). 
Groups  n  Dose 
Before 
experiment 
Before  
kelp-treated 
After kelp-treated 
Control group  10  General forage  151.76 ± 3.45  168.50 ± 4.22  189.69 ± 4.55 
DM-model group  10  General forage  151.85 ± 3.67  133.62 ± 5.35 
a  139.46 ± 5.36 
Low-dose group  10  1.25 g/kg kelp  151.68 ± 3.38  134.46 ± 5.23 
a  141.24 ± 5.32 
bc 
Medium-dose group  10  5.0 g/kg kelp  152.26 ± 3.51  135.27 ± 5.18 
a  150.24 ± 5.45 
b,c,d 
High-dose group  10  12.5 g/kg kelp  151.65 ± 3.43  133.55 ± 5.27 
a  151.56 ± 5.67 
b,c,d 
a P  <  0.05  vs.  before  experiment; 
b  P  <  0.05  vs.  before  kelp-treated; 
c  P  <  0.05  vs.  DM-model  group;  
d P < 0.05 vs. low-dose group. 
2.2. The Level of Fasting Blood Glucose (FBG) 
Before injecting alloxan, there were no obvious differences in FBG levels among the control group,  
DM-model rats and kelp-treated groups (F = 0.05, q = 0.03–0.55, P > 0.05). After injecting alloxan 
and before administering kelp powder forage, FBG levels increased significantly compared to those of 
DM-model rats and the control group (F = 79.52, q = 19.68–20.19, P < 0.05). There was no significant 
difference between kelp-treated groups and DM-model rats (P > 0.05). 
After administering kelp powder forage, FBG levels in kelp-treated groups were significantly lower 
than  in  the  DM-model  rats    and  higher  than  in  the  control  group  (F  =  189.19,  q  =  9.24–36.44,  
P < 0.05). After the  experiment, FBG levels in the DM-model rats  and kelp-treated  groups were 
significantly higher than in the control group (F = 188.99, q = 9.20–36.41, P < 0.05). There was no 
significant difference between the low-dose group and DM-model rats (P > 0.05). FBG levels in the 
medium-dose  group  and  high-dose  group  were  significantly  lower  than  in  the  DM-model  rats      
(P < 0.05) but there was no significant difference between the medium-dose group and the high-dose Int. J. Mol. Sci. 2012, 13                       
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group (P > 0.05). Results indicated that medium-dose kelp could achieve an ideal hypoglycemic effect 
(Table 2). 
Table 2. The levels of fasting blood glucose (FBG) in the experiment ( x ± s, mmol/L).  
Groups  n  Dose 
Before 
experiment 
Before  
kelp-treated 
After  
kelp-treated 
Control group  10  General forage  4.78 ± 0.39  4.95 ± 0.34  4.97 ± 0.33 
DM-model group  10  General forage  4.82 ± 0.33  17.86 ± 2.26 
a  13.32 ± 1.40
 b 
Low-dose group  10  1.25 g/kg kelp  4.55 ± 0.35  18.12 ± 2.28 
a  12.63 ± 1.67 
b 
Medium-dose group  10  5.0 g/kg kelp  4.81 ± 0.37  17.79 ± 2.31 
a  9.37 ± 1.70
b,c,d 
High-dose group  10  12.5 g/kg kelp  4.65 ± 0.34  18.05 ± 2.35 
a  9.18 ± 1.65
b,c,d 
a P  <  0.05  vs.  before  experiment; 
b  P  <  0.05  vs.  before  kelp-treated; 
c  P  <  0.05  vs.  DM-model  group;  
d P < 0.05 vs. low-dose group. 
2.3. The Serum Level of Insulin 
The serum levels of insulin in the DM-model group (11.23 ± 3.45, pmol/L) were significantly lower 
than in the control group (71.38 ± 15.26, pmol/L), while those in kelp-treated groups were significantly 
higher than those in the DM-model group (F = 13.250, q = 5.12–9.73, P < 0.05), but there were no 
significant differences between high-dose (26.22 ± 4.85, pmol/L), medium-dose (24.17 ± 5.09, pmol/L) 
and low-dose (18.78 ± 4.56, pmol/L) groups (P > 0.05). 
2.4. The Levels of MDA and NO and the Activities of SOD and GSH-Px 
Serum levels of MDA and NO were significantly higher and actions of SOD and GSH-Px were 
sharply lower in the DM-model rats and kelp-treaded groups than in the control group (F = 12.60,  
q = 3.72–7.17, P < 0.05). MDA and NO serum levels were significantly lower and actions of SOD and 
GSH-PX were higher in medium-dose and high-dose groups than in DM-model groups (P < 0.05). 
There was no significant difference between medium-dose and high-dose groups (P > 0.05). Results 
indicated that medium-dose kelp could achieve ideal anti-oxidant effect (Table 3). 
Table 3. The levels of malondialdehyde (MDA) and nitric oxide (NO) and the activities of 
superoxide  dismutase  (SOD)  and  glutathione  peroxidase  (GSH-Px)  in  the  experiment 
(x  ±  s). 
Groups  n  Dose  MDA(mmol/L)  NO(µmol/L)  SOD(U/mL)  GSH-Px(U/mL) 
Control group  10  General forage  7.15 ± 0.68  14.96 ± 1.56  156 ± 14.02  922 ± 22.16 
DM-model group  10  General forage  9.38 ± 1.24
a  23.86 ± 2.17 
a  122 ± 11.26 
a  828 ± 15.46 
a 
Low-dose group  10  1.25 g/kg kelp  8.93 ± 1.02  21.50 ± 2.24  127 ± 18.35  837 ± 24.82 
Medium-dose group  10  5.0 g/kg kelp  8.02 ± 0.45 
b,c  17.13 ± 1.41 
b,c  143 ± 22.26 
b,c  890 ± 24.58 
b,c 
High-dose group  10  12.5 g/kg kelp  7.83 ± 0.51 
b,c  16.32 ± 1.73 
b,c  145 ± 19.38 
b,c  886 ± 25.72 
b,c 
a P < 0.05 vsrsus control group; 
b P < 0.05 versus DM-model group; 
c P < 0.05 versus low-dose group. 
2.5. Pancreatic Islets Tissue Pathology  
The cells of pancreatic islets in the control group are oval in shape, uniform in size and evenly 
dispersed in the pancreatic gland bubble. DM-model rats have shrunken islets, a reduced number of Int. J. Mol. Sci. 2012, 13                       
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islet cells that are unevenly dispersed, vacuolar degeneration and karyolysis, etc. but this improved 
significantly in medium-dose and high-dose kelp-treated groups. The index of pancreatic B cells in 
medium-dose and high-doses kelp-treated groups is higher than in the DM-model rats (Table 4 and 
Figure 1). 
Table 4. The B cell index and the expressions of SOD and inducible nitric oxide synthase 
(iNOS) in the panreatic tissue ( x ± s). 
Groups  n  Dose  B cell index(%)  SOD (A)  iNOS(A) 
Control group  10  General forage  61.48 ± 9.13  0.48 ± 0.15  0.16 ± 0.05 
DM-model group  10  General forage  28.16 ± 5.64
 a  0.41 ± 0.12
 a  0.41 ± 0.12
 a 
Low-dose group  10  1.25g/kg kelp  31.49 ± 6.28  0.22 ± 0.08  0.35 ± 0.10 
Medium-dose group  10  5.0g/kg kelp  45.37 ± 6.82 
b  0.31 ± 0.10 
b  0.24 ± 0.09 
b 
High-dose group  10  12.5g/kg kelp  46.71 ± 7.36 
b  0.33 ± 0.12 
b  0.23 ± 0.08 
b 
a P < 0.05 versus control group; 
b P < 0.05 versus DM-model group. 
Figure 1. The comparison of the pancreatic islet cells. HE × 400, bar 25 µm. (A) Control 
group, (B) DM-model group, and (C) Medium-dose kelp-treated group. 
 
2.6. Immunohistochemistry of SOD and iNOS 
SOD expression in pancreatic islet cells of control group rats was strong and scattered focally with 
deep-yellow  color.  SOD  expression  was  reduced  in  DM-model  rats  (t  =  7.89,  P  <  0.05).  In  
medium-dose and high-dose kelp-treated group rats, SOD expression in islet cells was stronger than 
that in DM-model rats (t = 4.73–4.76, P < 0.05). There was no significant difference between the  
low-dose kelp-treated group and the DM-model rats (t = 1.69, P > 0.05). (Table 4 and Figure 2).  
Figure 2. The expression of inducible nitric oxide synthase (iNOS) in the pancreatic islet 
cells,  SABC  ×  400,  bar  25  µm.  (A)  Control  group,  (B)  DM-model  group,  and  (C)  
Medium-dose kelp-treated group. 
 
iNOS expression in pancreatic islet cells of control group rats was weak and scattered focally with 
light-yellow  color  and  was  significantly  stronger  in  DM-model  rats  (t  =  8.16,  P  <  0.05).  In  Int. J. Mol. Sci. 2012, 13                       
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medium-dose and high-dose kelp treated group rats, iNOS expression in islet cells was weaker than in 
the  DM-model  rats  (t  =  4.81–5.30,  P  <  0.05).  There  was  no  significant  difference  between  the  
low-dose kelp treated group and the DM-model rats (t = 1.90, P > 0.05). (Table 4 and Figure 3).  
Figure  3.  The  expression  of  superoxide  dismutase  (SOD)  in  the  pancreatic  islet  cells, 
SABC × 400, bar 25 µm. (A) Control group, (B) DM-model group, and (C) Medium-dose  
kelp-treated group. 
 
2.7. Discussion 
Hyperglycemia and oxidative stress are closely related to diabetes mellitus and its complications. 
The “common soil” theory of Ceriello et al. [15,16] holds that oxidative stress is a common feature of 
insulin  resistance,  diabetes  mellitus  and  cerebrovascular  diseases  [17].  In  a  body  suffering  from 
various harmful stimuli, there is an increase in free radicals and decreased elimination of those radicals 
can  upset  the  balance  of  the  oxidation  system  and  antioxidant  system,  and  damage  tissues  and  
function  [18,19].  At  the  same  time,  an  overflow  of  oxygen  free  radicals  (OFR)  causes  lipid 
peroxidation  (LPO),  which  increases  the  damage  of  the  oxidative  stress  through  a  chain  
reaction [20,21]. Diabetes mellitus patients with long-term hyperglycemia produce more OFR due to 
increased glucose autoxidation and protein saccharification, which weakens oxidation resistance and 
initiates oxidation stress [22]. Increased OFR plays an important role in initiating type 2 diabetes 
mellitus, insulin resistance and secondary effects, and the islet beta cell function obstacle. It becomes 
an important media for various factors that cause type 2 diabetes mellitus [23]. 
Alloxan  has  a  specific  toxic  effect  on  islet  beta  cells  that  can  cause  damage  by  producing  a 
superoxide radical, damage the DNA of the cell and activate polyphosphate ADP ribosomes synthase. 
This can reduce the coenzyme I, impair mRNA function and cause proinsulin decrease and insulin 
shortage [24]. In the process of diabetes mellitus development, the anti-oxidant defense level drops and 
the ability to eliminate free radicals weakens [25,26]. Bottino et al. [27] separated and purified islet 
cells by using an anti-oxidant to disrupt islet cells at an early stage and found that if blocking oxidative 
stress reduces damage to the islet cells and promotes their proliferation, it provides a new way of 
thinking  about  early  diagnosis  and  intervention  for  diabetes  mellitus.  Our  previous  researches 
confirmed  that  kelp  has  antioxidant  effects  on  the  organism  and  can  improve  the  oxidative  
stress [12,13]. 
In this experiment, the serum MDA and NO content in DM-model rats were significantly higher 
than  those  in  the  control  group.  The  action  of  serum  SOD  and  GSH-Px  in  DM-model  rats  was 
significantly less than in the control group. At the same time, SOD expression in pancreatic islet cells 
in the DM-model rats   was significantly lower and iNOS expression was higher than in the control 
group. The number of islet cells and beta cells reduced significantly and become partly pyknotic and Int. J. Mol. Sci. 2012, 13                       
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there was necrosis related to a decrease in serum insulin levels as well as increases in fasting blood 
glucose levels. Such features indicate that diabetes mellitus models, induced by alloxan, caused much 
lipid peroxidation in the rat body, injured the structure and secretion function of the islet cells and 
increased fasting blood glucose levels. 
After kelp powder was added to interfere with the diabetes mellitus models induced by alloxan, 
serum levels of MDA and NO decreased significantly and the actions of serum SOD and GSH-Px 
increased  in  comparison  with  the  DM-model  group.  Immunochemical  stain  showed  that  SOD 
expression in pancreatic islet cells was significantly higher and iNOS expression was lower than in the 
DM-model group. The structure of the pancreatic islet cells in kelp powder treated groups clearly 
improved in comparison with the DM-model group. Apparently, kelp enhances anti-oxidant enzyme 
activity, reduces lipid peroxidation (LPO) and products induced by diabetes mellitus and shows an 
antioxidant effect in the organism. Changes in fasting blood glucose (FBG) levels, serum insulin levels 
and animal weights show that FBG levels in kelp powder treated groups are significantly lower than in 
the  DM-model  group,  while  serum  insulin  levels  and  animal  weights  were  higher  than  in  the  
DM-model  group.  Results  indicate  that  kelp  could  play  a  hypoglycemic  role  by  enhancing  
anti-oxidation and enabling recovery of the pancreatic islet cell secreting function. 
3. Experimental Section 
3.1. The Creation of Diabetic Models 
Sixty SPF grade healthy male Wistar rats weighing 140–160 g were purchased from the Experiment 
Animal  Center  of  Qingdao  Drug  Inspection  Institute  (SCXK  (LU)  20090100).  Local  regulations 
related to ethical experimentation on animals and guidelines for the care and use of laboratory animals 
were followed in all  animal procedures in this  experiment. This experiment was  approved by  the 
Ethics  Committee  of  Qingdao  University  Medical  College  (No.  QUMC  2011-09).  Animals  were 
acclimatized for 7 days and allowed free access to food and water at room temperature (23 ± 2 °C) and 
humidity-controlled housing with natural illumination. Initially, an extracted blood sample (0.5 mL) 
from the tail vein was used for the serum separation and determination of fasting blood glucose (FBG) 
levels. Subsequently, ten (n = 10) experimental animals were randomized as a control group and injected 
with equivalent normal saline and the remaining 50 rats were injected intraperitoneally (i.p.) with 1.5% 
alloxan (100 mg/kg body weight), once every three days and three times continuously [28,29]. Three 
days after the final injection, the FBG level was determined and FBG > 15.00 mmol/L served as the 
standard in successful diabetes mellitus (DM) models. Ten of the 50 experimental rats were excluded 
because  they  did  not  satisfy  the  standard.  The  remaining  40  DM-model  rats  were  subjected  to 
experiment and randomly divided into a DM-model group (n = 10), and three kelp treated groups: a 
low-dose group (1.25 g/kg, n = 10), a medium-dose group (5.0 g/kg, n = 10) and a high-dose group 
(12.5 g/kg, n = 10). Int. J. Mol. Sci. 2012, 13                       
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3.1. The General Forage and Kelp Powder Forage 
The main components of the general forage: soybean meal 20.4 %, corn flour 31.7%, wheat bran 
7.2%, wheat flour 28.8%, fish meal 7.2%, yeast 2.4%, salt 0.2%, bone meal 1.4%, cod liver oil 0.04%, 
Vitamin E powder 0.04%, milk powder 0.18%, trace elements 0.04%. 
“Zhongke No.1” kelp powder forage is derived from kelp products manufactured at the Institute of 
Oceanology, Chinese Academy of Sciences. Chemical analysis shows the main components to be 
dietary  fiber  26.1%,  protein  8.5%,  lipid  0.39%,  total  amino  acid  10.49  mg/100g,  Vitamin  A  
273 µg/100g, and Vitamin C 3 µg/100g. 
The kelp powder forage used as an ingredient in the feed for the rats was pressed into a block, air 
dried and reserved. The low-dose forage contains general forage 97.5% and kelp powder 2.5%, the 
medium-dose forage contains general forage 90% and kelp powder 10%, and the high-dose forage 
contains general forage 75% and kelp powder 25%. 
3.2. Inference of Tests 
Rats in the control group and DM-model group   were fed with general forage for two weeks. Rats in 
the kelp-treated groups were fed with kelp powder forage for two weeks. 
The low-dose kelp powder (2.5%) equals 1.25g/kg body weight per day, the medium-does kelp 
powder (10%) equals 5.0 g/kg body weight per day and the high-dose kelp powder (25%) equals  
12.5 g/kg body weight per day. 
3.3. Preparation of Samples 
3.3.1. Serum preparation. At the end of this experiment, all rats were denied food for 12 h, then 
FBG was determined and 4 mL blood was collected from the eye artery using heparinized capillary 
tubes. Blood samples were centrifuged for 10 minutes at 4000 r/min to separate serum and then stored  
at −20 °C. 
3.3.2.  Pancreatic  tissue.  At  the  end  of  this  experiment,  animals  were  sacrificed  by  cervical 
dislocation and pancreatic tissues were immediately collected. Rudimental blood was fully washed 
with normal saline at −4 °C, and placed in 4% formaldehyde for fixing.  
3.4. Index of Determinations 
3.4.1. FBG Level 
An automatic blood glucose meter (Johnson & Johnson Medical Equipment Co., Ltd., Germany) 
and blood glucose test strips (Onetouch, Ultra) were used to detect FBG level (mmol/L). 
3.4.2. The Serum Level of Insulin 
Serum samples were thawed at room temperature and centrifuged again. Electrochemiluminescence 
immunoassay (ECLIA) was applied to determine the serum level of insulin with Elecsys 2010 and 
Cobase 411 analyzers and Roche diagnostics reagent kits (12017547). All standards were prepared 
before  starting  the  assay  procedure.  The  first  incubation:  insulin  from  20  µL  serum  sample,  a Int. J. Mol. Sci. 2012, 13                       
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biotinylated monoclonal insulin-specific antibody, and a monoclonal insulin-specific antibody labeled 
with  a  ruthenium  complex  form  a  sandwich  complex.  The  second  incubation:  after  addition  of 
streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of 
bitin  and  strepavidin.  Then  the  reaction  mixture  is  aspirated  into  the  measuring  cell  where  the 
microparticles are magnetically captured onto the surface of the electrode. Unbound substances are 
then removed with ProCell. A voltage is applied to the electrode to induce chemiluminescent emission 
which is measured by a photomultiplier. The results are determined via a calibration curve which is 
instrument-specifically generated by 2-point calibration and a master curve provided via the reagent 
barcode. Finally, the analyzer automatically calculates the analyte concentration of each sample. The 
measuring range of the assay is 1.39–6945 pmol/L. 
3.4.3. MDA and NO Values 
MDA  values  were  detected  by  thiobarbituric  acid  and  NO  values  were  detected  by  nitratase 
reductase using kits purchased from Jiancheng Institute of Biomedical Technology, Nanjing China. 
Standardization was conducted on an ultraviolet spectrophotometer (Bechmann DU640, USA) and the 
selected wavelengths were 532 nm for MDA and 550 nm for NO. Assay sensitivity is 0.1 mmol/L 
(MDA) and 0.1 µmol/L (NO). 
3.4.4. SOD and GSH-Px Activities 
SOD  action  was  detected  by  xanthinoxidase  and  GSH-Px  action  was  detected  by  chemical 
colorimetry  with  kits  supplied  by  Jiancheng  Institute  of  Biomedical  Technology,  Nanjing  China. 
Standardization was conducted on an ultraviolet spectrophotometer and the selected wavelengths were 
550 nm for SOD and 412 nm for GSH-Px. Assay sensitivity is 0.1 U/mL (SOD and GSH-Px). 
3.4.5. Histopathological Assay 
Pancreatic  tissue  samples  fixed  in  4%  formaldehyde  were  gradually  dehydrated  in  alcohol, 
hyalinized by dimethylbenzene, embedded in paraffin, sectioned at a thickness of 5 µm, adhered to 
sections  prepared  with  poly-L-Lysine  and  stored  at  4  °C.  Paraffin  sections  were  deparaffinaged 
deparaffinated  by  dimethylbenzene,  hydrated  in  gradient  ethanol  washed  with  distilled  water  and 
stained by Hematine-Eosin (HE) staining, that showed nuclei with a blue color and cytoplasm with a 
red color under light microscopy. Under a 400-fold light microscope, the average index of pancreatic B 
cells  was  calculated  in  five  views  selected  randomly  in  each  section  from  each  animal.  Index  of 
pancreatic B cell in each view = (the number of pancreatic islets B cells/total number of cells) × 100. 
3.4.6. Immunohistochemical Assay 
Rabbit  anti-rat  SOD  and  iNOS  multi-clonal  antibody,  and  strept  actividin-biotin  peroxidase 
complex  (SABC)  kit,  diaminobenzidine  (DAB)  kit  were  supplied  by  Wuhan  Boster  Biological 
Technology  Co.  Ltd.  China.  Paraffin-embedded  sections  were  deparaffinaged  in  dimethylbenzene, 
hydrated successively in gradient ethanol and antigen was restored twice in a microwave oven. All 
procedures  were  strictly  performed  in  accordance  with  the  manufacturer’s  directions.  Under  a Int. J. Mol. Sci. 2012, 13                       
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microscope, cells with brown granulation in cytoplasm or nucleus were considered to be positive. 
Negative control slides added 0.01 mol/L PBS (containing 1:200 blocking serum of non-immunized 
animals)  instead  of  a  primary  antibody  that  has  no  immunological  reaction.  Under  a  400×  light 
microscope, five sections were  randomly chosen from each experimental rat and observed in  five 
views  detected  in  islets.  Absorbance  values  (A)  of  each  view  were  detected  by  a  LEICA  Qwin 
microgramme analytical system (Leica Company, Shanghai, China). 
3.5. Statistical Analysis 
SPSS17.0  software  was  used  for  statistical  analysis.  Data  were  expressed  as  mean  ±  standard 
deviation (x ± s). Multi-group comparison was made by analysis of variance (ANOVA) and Student’s 
test and two-group comparison was by t-test. Values were considered to be significant when P < 0.05. 
4. Conclusions 
This study suggested that kelp might enable the recovery of islet cell secretion function and reduce 
the FBG level by an antioxidant effect. Future research should focus on the hypoglycemic effect and 
the mechanism of kelp. 
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